Cargando…
A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin
Beauvericin (BEA) is an emerging Fusarium mycotoxin that contaminates food and feeds globally. BEA biosynthesis is rapidly catalyzed by BEA synthetase through a nonribosomal, thiol-templated mechanism. This mycotoxin has cytotoxicity and is capable of increasing oxidative stress to induce cell apopt...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256083/ https://www.ncbi.nlm.nih.gov/pubmed/30515098 http://dx.doi.org/10.3389/fphar.2018.01338 |
_version_ | 1783374075986444288 |
---|---|
author | Wu, Qinghua Patocka, Jiri Nepovimova, Eugenie Kuca, Kamil |
author_facet | Wu, Qinghua Patocka, Jiri Nepovimova, Eugenie Kuca, Kamil |
author_sort | Wu, Qinghua |
collection | PubMed |
description | Beauvericin (BEA) is an emerging Fusarium mycotoxin that contaminates food and feeds globally. BEA biosynthesis is rapidly catalyzed by BEA synthetase through a nonribosomal, thiol-templated mechanism. This mycotoxin has cytotoxicity and is capable of increasing oxidative stress to induce cell apoptosis. Recently, large evidence further shows that this mycotoxin has a variety of biological activities and is being considered a potential candidate for medicinal and pesticide research. It is noteworthy that BEA is a potential anticancer agent since it can increase the intracellular Ca(2+) levels and induce the cancer cell death through oxidative stress and apoptosis. BEA has exhibited effective antibacterial activities against both pathogenic Gram-positive and Gram-negative bacteria. Importantly, BEA exhibits an effective capacity to inhibit the human immunodeficiency virus type-1 integrase. Moreover, BEA can simultaneously target drug resistance and morphogenesis which provides a promising strategy to combat life-threatening fungal infections. Thus, in this review, the synthesis and the biological activities of BEA, as well as, the underlying mechanisms, are fully analyzed. The risk assessment of BEA in food and feed are also discussed. We hope this review will help to further understand the biological activities of BEA and cast some new light on drug discovery. |
format | Online Article Text |
id | pubmed-6256083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62560832018-12-04 A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin Wu, Qinghua Patocka, Jiri Nepovimova, Eugenie Kuca, Kamil Front Pharmacol Pharmacology Beauvericin (BEA) is an emerging Fusarium mycotoxin that contaminates food and feeds globally. BEA biosynthesis is rapidly catalyzed by BEA synthetase through a nonribosomal, thiol-templated mechanism. This mycotoxin has cytotoxicity and is capable of increasing oxidative stress to induce cell apoptosis. Recently, large evidence further shows that this mycotoxin has a variety of biological activities and is being considered a potential candidate for medicinal and pesticide research. It is noteworthy that BEA is a potential anticancer agent since it can increase the intracellular Ca(2+) levels and induce the cancer cell death through oxidative stress and apoptosis. BEA has exhibited effective antibacterial activities against both pathogenic Gram-positive and Gram-negative bacteria. Importantly, BEA exhibits an effective capacity to inhibit the human immunodeficiency virus type-1 integrase. Moreover, BEA can simultaneously target drug resistance and morphogenesis which provides a promising strategy to combat life-threatening fungal infections. Thus, in this review, the synthesis and the biological activities of BEA, as well as, the underlying mechanisms, are fully analyzed. The risk assessment of BEA in food and feed are also discussed. We hope this review will help to further understand the biological activities of BEA and cast some new light on drug discovery. Frontiers Media S.A. 2018-11-20 /pmc/articles/PMC6256083/ /pubmed/30515098 http://dx.doi.org/10.3389/fphar.2018.01338 Text en Copyright © 2018 Wu, Patocka, Nepovimova and Kuca. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Wu, Qinghua Patocka, Jiri Nepovimova, Eugenie Kuca, Kamil A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin |
title | A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin |
title_full | A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin |
title_fullStr | A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin |
title_full_unstemmed | A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin |
title_short | A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin |
title_sort | review on the synthesis and bioactivity aspects of beauvericin, a fusarium mycotoxin |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256083/ https://www.ncbi.nlm.nih.gov/pubmed/30515098 http://dx.doi.org/10.3389/fphar.2018.01338 |
work_keys_str_mv | AT wuqinghua areviewonthesynthesisandbioactivityaspectsofbeauvericinafusariummycotoxin AT patockajiri areviewonthesynthesisandbioactivityaspectsofbeauvericinafusariummycotoxin AT nepovimovaeugenie areviewonthesynthesisandbioactivityaspectsofbeauvericinafusariummycotoxin AT kucakamil areviewonthesynthesisandbioactivityaspectsofbeauvericinafusariummycotoxin AT wuqinghua reviewonthesynthesisandbioactivityaspectsofbeauvericinafusariummycotoxin AT patockajiri reviewonthesynthesisandbioactivityaspectsofbeauvericinafusariummycotoxin AT nepovimovaeugenie reviewonthesynthesisandbioactivityaspectsofbeauvericinafusariummycotoxin AT kucakamil reviewonthesynthesisandbioactivityaspectsofbeauvericinafusariummycotoxin |